Encarnada, Josefa P.
HRN: 27-58-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2025
CEFUROXIME 750MG (VIAL)
08/06/2025
08/12/2025
IVTT
750 Mg
Q8
Uti
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: